Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 6.02B 905M 808M 742M 675M 1.27B 85.72B 1.29B 8.86B 3.57B 45.24B 3.4B 3.33B 143B P/E 2026 *
59.5x
P/E 2027 * 45.5x
Enterprise Value 6.02B 905M 808M 742M 675M 1.27B 85.72B 1.29B 8.86B 3.57B 45.24B 3.4B 3.33B 143B EV / Sales 2026 *
5.52x
EV / Sales 2027 * 4.86x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
Oct. 23 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 CI
Sep. 20 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
Aug. 24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
Jun. 03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
Apr. 22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
Apr. 20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
Apr. 06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
Mar. 31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
Dec. 15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
Dec. 14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
Nov. 03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
25-10-27 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
1 day+3.20%
1 week-9.55%
Current month+3.20%
1 month-30.26%
3 months-30.07%
6 months-13.56%
Current year+31.88%
1 week 22.26
Extreme 22.26
25.18
1 month 22.26
Extreme 22.26
33.67
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 2024-04-14
Director of Finance/CFO 45 2022-11-28
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 2025-10-30
Chairman 47 2023-12-31
Director/Board Member 54 2015-04-05
Change 5-day change 1-year change 3-year change Capi.($)
+3.20%-9.55%+35.41%+87.33% 905M
+3.44%+6.13%+24.10%+11.28% 22.64B
+0.65%+1.22%-12.83%+60.15% 19.93B
+2.41%+5.62%+44.83%+39.37% 18.02B
+2.63%+1.95%+6.93%+6.13% 14.17B
+3.35%+5.60%+26.82%+52.09% 13.16B
+1.84%+2.49%+27.81%+81.29% 12.19B
+4.85%+13.21%+24.01%+16.41% 9.12B
-0.51%-5.59%-6.41%-20.41% 8.33B
0.00%0.00%+128.40%+757.19% 6.73B
Average +2.19%+2.80%+29.91%+109.08% 12.52B
Weighted average by Cap. +2.24%+3.61%+23.56%+72.56%

Financials

2026 *2027 *
Net sales 1.09B 164M 146M 134M 122M 229M 15.52B 234M 1.6B 646M 8.19B 615M 602M 25.87B 1.24B 186M 166M 153M 139M 260M 17.62B 265M 1.82B 734M 9.3B 699M 684M 29.38B
Net income 103M 15.49M 13.83M 12.69M 11.54M 21.64M 1.47B 22.07M 152M 61.09M 774M 58.12M 56.89M 2.44B 137M 20.6M 18.39M 16.88M 15.35M 28.78M 1.95B 29.36M 202M 81.25M 1.03B 77.31M 75.66M 3.25B
Net Debt - -
Projected Income Statement - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
26-11-02 CN¥23.21 +3.20% 9,304,267
26-10-30 CN¥22.49 -5.70% 7,535,839
26-10-29 CN¥23.85 -4.14% 6,894,205
26-10-28 CN¥24.88 +3.80% 9,546,897
26-10-27 CN¥23.97 -6.59% 7,347,987

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 301188 Stock